Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Open in API
Filings indexed 648 across all filing types
Latest filing 2013-12-18 Regulatory Filings
Country SE Sweden
Listing ST GETI

About Getinge

https://www.getinge.com/int/

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
Affärsområdet Medical Systems förbättrar kvalitetsledningssystem efter inspektioner av amerikanska FDA
Regulatory Filings Classification · 95% confidence The document is a press release dated 2013-12-18, written in Swedish, announcing that the Medical Systems division is improving its quality management systems following inspections by the US FDA (Food and Drug Administration). This announcement concerns regulatory interactions and potential compliance issues related to medical devices, which falls under the scope of legal/regulatory matters or general regulatory announcements. It is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific shareholder action (DIV, DVA). Since it details interactions with a regulatory body (FDA) regarding operational compliance and improvements, it best fits the category for legal proceedings or regulatory actions. Given the options, 'Legal Proceedings Report' (LTR) is the closest fit for reporting on regulatory findings and subsequent corrective actions, although 'Regulatory Filings' (RNS) is a possible fallback. However, reporting on specific regulatory findings and corrective actions is more specific than a general RNS filing. I will classify it as LTR due to the focus on regulatory findings and required improvements.
2013-12-18 Swedish
Medical Systems Business Area enhancing its manufacturing quality systems following U.S. FDA inspections
Legal Proceedings Report Classification · 99% confidence The document is a short press release dated 2013-12-18 concerning the Medical Systems Business Area of Getinge Group addressing observations from U.S. FDA inspections and announcing improvements to quality management systems. It is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It details a specific regulatory/legal matter (FDA observations) that impacts operations and quality compliance. This fits best under Legal Proceedings Report (LTR) as it discusses regulatory findings and subsequent corrective actions, which often involve regulatory scrutiny or potential enforcement actions, or potentially Regulatory Filings (RNS) as a general announcement. Given the focus on FDA findings and necessary improvements, LTR is a strong candidate, but since it is a general press release about compliance status rather than a formal legal filing update, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for non-standard regulatory news that doesn't fit LTR (which usually implies active litigation or formal enforcement). However, since it directly addresses regulatory findings (FDA inspections), LTR is slightly more specific than RNS. I will classify it as LTR due to the direct mention of FDA inspections and observations, which are regulatory actions impacting the business.
2013-12-18 English
Getinge Group appoints Harald F. Stock as new President and CEO of ArjoHuntleigh and Executive Vice President Extended Care Business Area
Board/Management Information Classification · 99% confidence The document is a press release dated 2013-12-09 announcing a significant change in senior management: the appointment of Harald F. Stock as the new President and CEO of ArjoHuntleigh and Executive Vice President Extended Care Business Area, succeeding Alex Myers. This directly matches the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2013-12-09 English
Getingekoncernen utser Harald F. Stock till ny VD för ArjoHuntleigh och Executive Vice President för affärsområdet Extended Care
Board/Management Information Classification · 99% confidence The document is a press release (Pressmeddelande) announcing a significant change in senior management: the appointment of Harald F. Stock as the new CEO for ArjoHuntleigh and EVP for the Extended Care business area, succeeding Alex Myers. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2013-12-09 Swedish
Shareholders representing 70% of outstanding shares in Pulsion have agreed to accept Getinges offer in intended acquisition of Pulsion Medical Systems
M&A Activity Classification · 98% confidence The document is a press release dated December 5, 2013, announcing that shareholders representing 70% of Pulsion have agreed to accept Getinge's tender offer for acquisition. This clearly describes an event related to a merger proposal or takeover bid involving two companies (Getinge and Pulsion). According to the definitions, this falls under M&A Activity (TAR). The document is not a formal regulatory filing like a 10-K or an IR, nor is it a general announcement of a report publication (RPA). It is a specific announcement about a takeover transaction.
2013-12-05 English
Aktieägare som representerar 70 % av utgivna aktier i Pulsion har accepterat Getinges erbjudande avseende förvärvet av Pulsion Medical Systems SE
M&A Activity Classification · 98% confidence The document is a press release from Getinge AB concerning a public offer to acquire all shares in Pulsion Medical Systems SE. It details the cash offer price (€16.90 per share) and notes that a significant majority (70%) of shareholders have irrevocably committed to accept the offer. This clearly falls under the category of a merger or takeover proposal/activity. Based on the definitions, this corresponds to 'M&A Activity' (Code: TAR). The document length is short (2464 chars), but it is the primary announcement of the takeover bid itself, not just an announcement *about* a report, making TAR more specific than RPA or RNS.
2013-12-05 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.